Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

890
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
890
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

312
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
312
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

360
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
360
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

869
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
869
Inflammation01:38

Inflammation

61.6K
Overview
61.6K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

455
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
455

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Vitexin Ameliorates HG-Induced Injury in Retinal ARPE-19 Cells by Targeting CASP3.

Journal of biochemical and molecular toxicology·2026
Same author

Comparison of clinical efficacy between endoscope-assisted oblique lumbar interbody fusion and posterior lumbar interbody fusion in the treatment of lumbar degenerative diseases.

Frontiers in surgery·2026
Same author

Cu Doping Regulates the Local Structure of CoAl Layered Double Hydroxides for Enhanced Photocatalytic Nitrogen Fixation.

Langmuir : the ACS journal of surfaces and colloids·2026
Same author

Impact of bone cement leakage on early postoperative pain in percutaneous vertebroplasty for osteoporotic vertebral compression fractures.

Frontiers in surgery·2026
Same author

Self-Powered Piezoelectric Nanofibrous Hydrogel for Synergistic Electro-Pharmacological Therapy of Chronic Wounds.

Advanced healthcare materials·2026
Same author

Ion-shielding ultrathin encapsulation with hot-press bonded interface enables chronic stretchable bioelectronics.

Science advances·2026

Video Experimental Relacionado

Updated: Jan 13, 2026

A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium
11:00

A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium

Published on: June 22, 2010

29.7K

RhoA acelera la progresión de la aterosclerosis al interactuar con Hspa5

Ruoyu Dong1, Can Cao2, Jikuan Li1

  • 1Department of Vascular Surgery, Hebei General Hospital, No.348, Heping West Road, Shijiazhuang, 050000, Hebei, China.

Scientific reports
|January 6, 2026
PubMed
Resumen

La proteína RhoA promueve la aterosclerosis (AS) al mejorar la migración y la mitofagia de las células del músculo liso vascular. La focalización de RhoA y su interacción con Hspa5 puede ofrecer nuevas estrategias terapéuticas para el tratamiento de la AS.

Palabras clave:
AterosclerosisHspa5MitofagiaRhoACélulas del músculo liso vascular

Más Videos Relacionados

The Rabbit Model of Accelerated Atherosclerosis: A Methodological Perspective of the Iliac Artery Balloon Injury
09:14

The Rabbit Model of Accelerated Atherosclerosis: A Methodological Perspective of the Iliac Artery Balloon Injury

Published on: October 3, 2017

12.7K
A Novel Stretching Platform for Applications in Cell and Tissue Mechanobiology
16:46

A Novel Stretching Platform for Applications in Cell and Tissue Mechanobiology

Published on: June 3, 2014

12.2K

Videos de Experimentos Relacionados

Last Updated: Jan 13, 2026

A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium
11:00

A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium

Published on: June 22, 2010

29.7K
The Rabbit Model of Accelerated Atherosclerosis: A Methodological Perspective of the Iliac Artery Balloon Injury
09:14

The Rabbit Model of Accelerated Atherosclerosis: A Methodological Perspective of the Iliac Artery Balloon Injury

Published on: October 3, 2017

12.7K
A Novel Stretching Platform for Applications in Cell and Tissue Mechanobiology
16:46

A Novel Stretching Platform for Applications in Cell and Tissue Mechanobiology

Published on: June 3, 2014

12.2K

Área de la Ciencia:

  • Biología Cardiovascular
  • Medicina Molecular
  • Biología Celular

Sus antecedentes:

  • La aterosclerosis (AS) es una enfermedad cardiovascular compleja.
  • Los mecanismos reguladores precisos de RhoA en la AS siguen sin estar claros.

Objetivo del estudio:

  • Investigar el papel y los mecanismos subyacentes de RhoA en la progresión de la AS.
  • Explorar la interacción entre RhoA y Hspa5 en el contexto de la AS.

Principales métodos:

  • Se estableció un modelo de ratón con AS inducida por dieta alta en grasas.
  • Se utilizaron virus adenoasociados para la manipulación de RhoA in vivo.
  • Se analizaron células de músculo liso vascular aórtico de ratón (MOVAS) tratadas con lipoproteínas de baja densidad oxidadas (ox-LDL) utilizando diversos ensayos (kit de recuento celular-8, migración Transwell, microscopía electrónica, western blot).
  • Se investigó la interacción RhoA-Hspa5 mediante análisis bioinformático, co-inmunoprecipitación e inmunofluorescencia.

Principales resultados:

  • RhoA se reguló significativamente en ratones con AS y se localizó en la capa muscular lisa aórtica.
  • La inhibición de RhoA suprimió la viabilidad, migración, invasión y mitofagia de las células MOVAS in vitro, y redujo la formación de placas de AS y la inflamación in vivo.
  • Se identificó que Hspa5 interactúa con RhoA, con una correlación positiva entre su expresión y los niveles de RhoA.
  • La sobreexpresión de Hspa5 revirtió los efectos inhibitorios del silenciamiento de RhoA en los comportamientos celulares y la progresión de la AS.

Conclusiones:

  • RhoA promueve la AS al mejorar la migración, invasión y mitofagia de las células del músculo liso vascular a través de la interacción con Hspa5.
  • RhoA desempeña un papel crítico en la exacerbación de la progresión de la AS.
  • RhoA representa un objetivo terapéutico potencial para el manejo de la aterosclerosis.